Telcare, LLC: Device Recall

Recall #Z-1270-2025 · 01/30/2025

Class II: Risk

Recall Details

Recall Number
Z-1270-2025
Classification
Class II
Product Type
Device
Recalling Firm
Telcare, LLC
Status
Ongoing
Date Initiated
01/30/2025
Location
Concord, MA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
34,764 units

Reason for Recall

Telcare, LLC has received customer complaints related to battery expansion/swelling for its Philips Connected Blood Glucose Meter (i.e., BGM 4 brand name) Monitoring System.. The issue was identified by post market surveillance data (customer complaints) - events of battery expansion/swelling and associated symptoms, e.g., leading to the device's removable back cover (battery port) to separate. If there is a loss of primary function of the device due to the described device defect, an immediate health consequence that may result is prolonged hypoglycemia or hyperglycemia due to delay in treatment, as the blood glucose measurement is not available to guide treatment. In a worst-case situation, there is potential for battery swelling to result in explosion of the battery and/ or device. Exposure to explosion, and subsequently projectiles from the explosion, may result in several immediate health consequences, including concussion, headache, dizziness, eye irritation, blurred vision, eye injury, and vision impairment.

Product Description

Philips Connected Blood Glucose Meter, BGM 4; Model Number: TM0009;

Distribution Pattern

US Nationwide distribution.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.